COMPLIANCE An Observational Study of Treatment Compliance and Quality of Life in Patients on Antihypertensive Medication

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01274494

Enrollment

1501

Registered

2011-01-11

Start date

2011-05-31

Completion date

2012-09-30

Last updated

2013-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Blood Pressure

Keywords

Hypertension

Brief summary

The aim of this multi-centre survey is to assess treatment adherence and quality of life in a Jordanian and Lebanese population newly diagnosed with hypertension or with uncontrolled essential hypertension being on antihypertensive treatment for at least 6 months.

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

21 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients older than 21 years of age * Patients newly diagnosis with essential hypertension or with hypertension that is uncontrolled after being under the same antihypertensive treatment for at least 6 months (based on the criteria established by the Joint National Committee VII) * Patients capable of providing an informed consent

Exclusion criteria

* Patients with secondary hypertension * Pregnant women or nursing mothers * Patients with acute illnesses or psychiatric diagnosis

Design outcomes

Primary

Measure	Time frame	Description
Compliance rate	6 months	Identify the percentage of subjects compliant to their antihypertensive treatment.

Secondary

Measure	Time frame	Description
Health Related Quality of Life (MINICHAL Score)	6 months	To compare and identify changes in the quality of life before and after anti-hypertensive treatment.
Type of pharmacological treatments	6 months	To identify the pharmacological treatments used by physicians in Jordan and Lebanon to treat patients newly diagnosed or with uncontrolled hypertension.
Factors affecting adherence to treatment	6 months	To identify associated factors that may alter adherence to anti-hypertensive treatment.
Compliance rate by antihypertensive regimen used	6 months	To compare treatment rate for different antihypertensive regimen used
Percentage of controlled patients	6 months	To identify the percentage of patients reaching their target blood pressure according to the JNCVII criteria.

Outcome results